Search

everythinglearnresearchcommunity

for

Search:↓

Breathing in high levels of certain air pollutants significantly increases women's risk of developing Polycystic Ovary Syndrome.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Some birth control pills increase young women's risk of blood clots more than others.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Spironolactone might lower the chance of getting rosacea.

Baldness may lower the risk of testicular cancer.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Finasteride use may increase the risk of male breast cancer.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

DHT may increase the risk of heart disease and death in elderly men.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.